Rapidly Involuting Congenital Hemangioma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

RICH MCID: RPD005 MIFTS: 46	Rapidly Involuting Congenital Hemangioma (RICH) Categories: Cancer diseases, Cardiovascular diseases, Fetal diseases, Rare diseases
Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Name: Rapidly Involuting Congenital Hemangioma ⁵⁸

Rich ⁵⁸

Characteristics:

Orphanet epidemiological data:

⁵⁸

rapidly involuting congenital hemangioma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

MalaCards categories:
Global: Fetal diseases Rare diseases Cancer diseases
Anatomical: Cardiovascular diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Neoplasms

Benign neoplasms

Haemangioma and lymphangioma, any site

Haemangioma, any site

Orphanet: ⁵⁸

Rare circulatory system diseases

Developmental anomalies during embryogenesis

External Ids:

ICD10 via Orphanet ³³ D18.0

UMLS via Orphanet ⁷² C1275421

Orphanet ⁵⁸ ORPHA141184

SNOMED-CT via HPO ⁶⁸ 17141001 240196003 248315005 more

Sources

Summaries for Rapidly Involuting Congenital Hemangioma

MalaCards based summary : Rapidly Involuting Congenital Hemangioma, also known as rich, is related to hemangioma and congenital hemangioma. The drugs Borage oil and Linagliptin have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and endothelial, and related phenotypes are telangiectasia of the skin and subcutaneous calcification

Wikipedia : ⁷⁴ A vascular tumor is a tumor of vascular origin; a soft tissue growth that can be either benign or... more...

Sources

Related Diseases for Rapidly Involuting Congenital Hemangioma

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 22)

#	Related Disease	Score
1	hemangioma	10.9
2	congenital hemangioma	10.9
3	non-involuting congenital hemangioma	10.5
4	arteriovenous malformation	10.3
5	thrombocytopenia	10.3
6	hemangioendothelioma	10.3
7	kaposiform hemangioendothelioma	10.3
8	rare tumor	10.3
9	angioma, tufted	10.2
10	deficiency anemia	10.2
11	toxic shock syndrome	10.2
12	vascular cancer	10.2
13	teratoma	10.2
14	fibrosarcoma	10.2
15	thrombophlebitis	10.2
16	liver disease	10.2
17	congenital fibrosarcoma	10.2
18	cleft lip	10.2
19	fasciitis	10.2
20	necrotizing fasciitis	10.2
21	posttransplant acute limbic encephalitis	10.2
22	rare vascular tumor	10.2

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:

Sources

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

⁵⁸ ³¹ (show all 14)

#	Description	HPO Frequency	Orphanet Frequency	HPO Source Accession
1	telangiectasia of the skin ⁵⁸ ³¹	frequent (33%)	Frequent (79-30%)	HP:0100585
2	subcutaneous calcification ⁵⁸ ³¹	frequent (33%)	Frequent (79-30%)	HP:0007618
3	midfrontal capillary hemangioma ⁵⁸ ³¹	frequent (33%)	Frequent (79-30%)	HP:0007466
4	perineal hemangioma ⁵⁸ ³¹	frequent (33%)	Frequent (79-30%)	HP:0031449
5	congestive heart failure ⁵⁸ ³¹	occasional (7.5%)	Occasional (29-5%)	HP:0001635
6	thrombocytopenia ⁵⁸ ³¹	occasional (7.5%)	Occasional (29-5%)	HP:0001873
7	peripheral arteriovenous fistula ⁵⁸ ³¹	occasional (7.5%)	Occasional (29-5%)	HP:0100784
8	prominent superficial veins ⁵⁸ ³¹	occasional (7.5%)	Occasional (29-5%)	HP:0001015
9	avascular necrosis ⁵⁸ ³¹	very rare (1%)	Very rare (<4-1%)	HP:0010885
10	lipoatrophy ⁵⁸ ³¹	very rare (1%)	Very rare (<4-1%)	HP:0100578
11	hepatic hemangioma ⁵⁸ ³¹	very rare (1%)	Very rare (<4-1%)	HP:0031207
12	hemangioma ⁵⁸		Obligate (100%)
13	visceral hemangioma ⁵⁸		Occasional (29-5%)
14	tufted angioma ⁵⁸		Excluded (0%)

Sources

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 529)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Borage oil

Approved, Investigational

Phase 4

Linagliptin

Approved

Phase 4

668270-12-0

10096344

Glycerol

Approved, Investigational

Phase 4

56-81-5

753

Menthol

Approved

Phase 4

2216-51-5

16666

Calcium carbonate

Approved, Investigational

Phase 4

471-34-1

Atorvastatin

Approved

Phase 4

134523-00-5

60823

Sodium citrate

Approved, Investigational

Phase 4

68-04-2

Artichoke

Approved

Phase 4

Ketamine

Approved, Vet_approved

Phase 4

6740-88-1

3821

Potassium citrate

Approved, Investigational, Vet_approved

Phase 4

866-84-2

Allopurinol

Approved

Phase 4

315-30-0

2094

Hyaluronic acid

Approved, Vet_approved

Phase 4

9004-61-9

53477741

Betamethasone

Approved, Vet_approved

Phase 4

378-44-9

9782

Lenograstim

Approved, Investigational

Phase 4

135968-09-1

Sargramostim

Approved, Investigational

Phase 4

123774-72-1, 83869-56-1

Mannitol

Approved, Investigational

Phase 4

69-65-8

453 6251

Nitroglycerin

Approved, Investigational

Phase 4

55-63-0

4510

Febuxostat

Approved

Phase 4

144060-53-7

134018

Guanfacine

Approved, Investigational

Phase 4

29110-47-2

3519

Amoxicillin

Approved, Vet_approved

Phase 4

26787-78-0

33613

Clavulanate

Approved, Vet_approved

Phase 4

58001-44-8

5280980

Clindamycin

Approved, Vet_approved

Phase 4

18323-44-9

29029

Chlorhexidine

Approved, Vet_approved

Phase 4

55-56-1

9552079 2713

Guaifenesin

Approved, Investigational, Vet_approved

Phase 4

93-14-1

3516

Triamcinolone

Approved, Vet_approved

Phase 4

124-94-7

31307

Adenosine

Approved, Investigational

Phase 4

58-61-7

60961

Aspirin

Approved, Vet_approved

Phase 4

50-78-2

2244

Clopidogrel

Approved

Phase 4

120202-66-6, 113665-84-2

60606

Ticagrelor

Approved

Phase 4

274693-27-5

9871419

Citric acid

Approved, Nutraceutical, Vet_approved

Phase 4

77-92-9

311

Cysteine

Approved, Nutraceutical

Phase 4

52-90-4

5862

Vitamin D

Approved, Nutraceutical, Vet_approved

Phase 4

1406-16-2

Lecithin

Experimental

Phase 4

8002-43-5

Molgramostim

Investigational

Phase 4

99283-10-0

Uric acid

Investigational

Phase 4

69-93-2

1175

Borage

Phase 4

Dipeptidyl-Peptidase IV Inhibitors

Phase 4

Aloe

Phase 4

Arnica

Phase 4

Gotu Kola

Phase 4

Devil's Claw

Phase 4

Citrate

Phase 4

Hemostatics

Phase 4

Coagulants

Phase 4

Anesthetics, Local

Phase 4

Respiratory System Agents

Phase 4

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Phase 4

Lipid Regulating Agents

Phase 4

Hypolipidemic Agents

Phase 4

Antimetabolites

Phase 4

Interventional clinical trials:

(show top 50) (show all 1182)

#	Name	Status	NCT ID	Phase	Drugs
1	The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial	Unknown status	NCT03261843	Phase 4
2	Application of Platelet-Rich-Plasma in Posterolateral Lumbar Fusion	Unknown status	NCT03779945	Phase 4
3	Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial	Unknown status	NCT02999737	Phase 4
4	Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study.	Unknown status	NCT01509274	Phase 4
5	Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial	Unknown status	NCT02438046	Phase 4
6	Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients	Unknown status	NCT02280174	Phase 4	linagliptin
7	Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems	Unknown status	NCT01583491	Phase 4
8	Effect of Biphasic Bone Graft Material (BGM) in Combination With Autologous Platelet-rich Fibrin (PRF) on Bone Regeneration in an Odontogenic Maxillary Cyst: a Randomized Clinical Trial	Unknown status	NCT03003013	Phase 4
9	Irritation and Anal Bleeding in Patients Affected by Hemorrhoids: Comparative Evaluation of Three Different Treatments.	Unknown status	NCT03569930	Phase 4	flavonoid-based supplements;Centella Complex
10	Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study	Unknown status	NCT02006303	Phase 4
11	Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study	Unknown status	NCT02338687	Phase 4
12	Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study)	Completed	NCT03231137	Phase 4	ATV gel
13	Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series	Completed	NCT02521467	Phase 4
14	Platelet Rich Fibrin (PRF) Membranes in Lateral Alveolar Ridge Augmentation. A Randomized Controlled Study Comparing an Autogenous Bone Graft Covered by a Platelet Rich Fibrin (PRF) Membrane (Test Group) or an Anorganic Bovine Bone Substitute and a Resorbable Collagen Barrier Membrane (Control Group)	Completed	NCT04350749	Phase 4
15	The Comparison of Knee Osteoarthritis Treatment With Single-dose of Bone Marrow Aspirate Concentrate, Single-dose of Leukocyte Rich Platelet Rich Plasma and 3 Injection of High Molecular Weight Hyaluronic Acid-A Randomized Clinical Trial	Completed	NCT03825133	Phase 4	Hyaluronic Acid
16	Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement	Completed	NCT00826098	Phase 4
17	Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.	Completed	NCT03444233	Phase 4
18	EFFECTS OF A DIET RICH IN N-3 POLYUNSATURATED FATTY ACIDS ON SYSTEMIC INFLAMMATION IN RENAL TRANSPLANT RECIPIENTS	Completed	NCT01872455	Phase 4
19	The Effect of Autologous Application of Platelet Rich Plasma on Wound Healing and Pain Perception After Cesarean Section in a Low Resource Setting	Completed	NCT04669353	Phase 4	Platelet rich plasma
20	The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial	Completed	NCT00761423	Phase 4
21	Energy-restricted, n-3 Polysaturated Fatty Acids-rich Diet Improves the Clinical Response to Immuno-modulating Drugs in Obese Patients With Plaque-type Psoriasis: a Randomized Control Clinical Trial.	Completed	NCT01876875	Phase 4
22	A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers.	Completed	NCT00770939	Phase 4
23	Combined Platelet Rich Plasma Intra-articular Shoulder Injection and Stellate Ganglion Block. A New Technique for Management of Chronic Post-mastectomy Shoulder Pain Syndrome	Completed	NCT03586154	Phase 4	ketamine and bupivacaine injection
24	Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors	Completed	NCT00168987	Phase 4	oral nutritional supplement rich in eicosapentanoic acid
25	Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT)Combined With Intravascular Ultrasound (IVUS)	Completed	NCT01023607	Phase 4	Atorvastatin;Atorvastatin;Rosuvastatin
26	Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months	Completed	NCT02189408	Phase 4
27	'A Comparison of Platelet Rich Fibrin & Mineralised Freezed Dried Bone Allograft to Radiographically Evaluate Healing Post Endodontic Surgery'- an In-vivo Study	Completed	NCT04377698	Phase 4
28	Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study.	Completed	NCT01111747	Phase 4
29	Efficacy of Bone Marrow Aspirate Concentrate Compared With Platelet Rich Plasma for the Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Controlled Clinical Trial	Completed	NCT03289416	Phase 4
30	Comparative Study Between Intra Articular Injection of Hyaluronic Acid (HA) With Platelet Rich Plasma (PRP) Versus Genicular Nerve Thermal Radiation in Management of Pain in Knee Osteoarthritis	Completed	NCT04188561	Phase 4	Intra articular injection Group
31	Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial	Completed	NCT02369250	Phase 4	Rosuvastatin
32	Platelet-rich Plasma (PRP) vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology: a Randomized Double-blind Controlled Trial	Completed	NCT01670578	Phase 4
33	Does Post-Operative Intra-Articular Platelet Rich Plasma Injection Improve Meniscal Repair Outcomes	Completed	NCT03910036	Phase 4
34	The Efficacy of Ultrasound Guided Glenohumeral Joint Injections of Platelet Rich Plasma (PRP) Versus Hyaluronic Acid (HA) in the Treatment of Glenohumeral Osteoarthritis: a Randomized, Double-blind Control Trial	Completed	NCT02984228	Phase 4	Hyaluronic Acid
35	A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates	Completed	NCT03403530	Phase 4	IgM rich Immunoglobin
36	Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study	Completed	NCT02256891	Phase 4
37	Effects of Application Injectable Platelet-Rich Fibrin (i-PRF) as Adjunct Therapy in the Initial Treatment of Periodontitis	Completed	NCT04178590	Phase 4	SRP + Injectable Platelet-Rich Fibrin;SRP + placebo
38	The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial	Completed	NCT04743986	Phase 4	Corticosteroid (CS)
39	Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function	Completed	NCT01662414	Phase 4
40	Plasma Rich in Growth Factors Effectiveness for Myofascial Pain Treatment in Masticatory Muscles: a Randomized Controlled Clinical Trial	Completed	NCT04040309	Phase 4	Lidocaine injection
41	Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis	Completed	NCT00782197	Phase 4
42	Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee.	Completed	NCT03086759	Phase 4	Triamcinolone Hexacetonide
43	Palatal Wound Healing Evaluation After Application of Platelet Rich Fibrin Versus 0.2% Hyaluronic Acid Dressings (Randomized Controlled Clinical Trial)	Completed	NCT04390100	Phase 4	hyaluronic acid (Gengiegel 0.2% oral gel )
44	Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial	Completed	NCT01990690	Phase 4	anti oxidant omega 3
45	Dietary Nitrate Supplementation and Cardiorespiratory Control in Chronic Heart Failure: a Randomized, Placebo-controlled Trial	Completed	NCT02401126	Phase 4
46	The Predictors of Successful Oral Dissolution Therapy in Radiolucent Renal Stones; A Prospective Evaluation	Completed	NCT02373384	Phase 4	Oral alkalinization (Potassium citrate, Allopurinol)
47	the Effect of Adipose Derived Stem Cells Combined With Platelet Rich Plasma Versus Platelet Rich Plasma Alone on Follicular Unit Extraction Hair Transplantion in Male Androgenic Alopecia: Clinical Trial	Recruiting	NCT03388840	Phase 4
48	Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back Pain	Recruiting	NCT04544709	Phase 4	Low back intradiscal injection of platelet rich plasma (PRP)
49	The Effect of Proprioception of Platelet Rich Plasma for Patients With Ankle Sprain	Recruiting	NCT03808454	Phase 4	PRP
50	The Impact of Using Granulocyte Colony Stimulating Factor (G-CSF) Versus Platelet Rich Plasma (PRP) on the Outcomes of Frozen Embryo Transfer; Double-blinded Randomized Placebo-controlled Trial (Endotrial)	Recruiting	NCT03945812	Phase 4	Granulocyte Colony Stimulating Factor

Search NIH Clinical Center for Rapidly Involuting Congenital Hemangioma

Sources

Genetic Tests for Rapidly Involuting Congenital Hemangioma

Sources

Anatomical Context for Rapidly Involuting Congenital Hemangioma

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

⁴⁰

Bone, Bone Marrow, Endothelial, Skin, Prostate, Skeletal Muscle, Colon

Sources

Publications for Rapidly Involuting Congenital Hemangioma

Articles related to Rapidly Involuting Congenital Hemangioma:

(show top 50) (show all 30040)

#	Title	Authors	PMID	Year
1	Fat grafting and platelet-rich plasma in wound healing: a review of histology from animal studies. ⁶¹	Nolan GS...Mosahebi A	33525977	2021
2	Flavonoids and caffeoylquinic acids in Chrysanthemum morifolium Ramat flowers: A potentially rich source of bioactive compounds. ⁶¹	Chen S...Liu A	33280963	2021
3	Two-stage selective enzymatic hydrolysis generates protein hydrolysates rich in Asn-Pro and Ala-His for enhancing taste attributes of soy sauce. ⁶¹	Zhao Y...Su G	33310561	2021
4	Laser light as a promising approach to improve the nutritional value, antioxidant capacity and anti-inflammatory activity of flavonoid-rich buckwheat sprouts. ⁶¹	Almuhayawi MS...AbdElgawad H	33340896	2021
5	Xanthine oxidase inhibitory activity and antihyperuricemic effect of Moringa oleifera Lam. leaf hydrolysate rich in phenolics and peptides. ⁶¹	Tian Y...Zhao K	33450289	2021
6	N-rich porous organic polymers based on Schiff base reaction for CO2 capture and mercury(II) adsorption. ⁶¹	Sang Y...Liu YN	33360884	2021
7	Magnetic N-rich carbon nitride framework material for the high selectivity extraction and determination of La(III). ⁶¹	Kang JY...Shi YP	33592797	2021
8	Anthocyanin-rich extracts from purple and red potatoes as natural colourants: Bioactive properties, application in a soft drink formulation and sensory analysis. ⁶¹	Sampaio SL...Barros L	33223300	2021
9	Self-grown oxygen vacancies-rich CeO2/BiOBr Z-scheme heterojunction decorated with rGO as charge transfer channel for enhanced photocatalytic oxidation of elemental mercury. ⁶¹	Jia T...Qi X	33370662	2021
10	Recovering gaseous Hg0 using sulfureted phosphotungstic acid modified γ-Fe2O3 from power plants burning Hg-rich coal for centralized control. ⁶¹	Wang C...Yang S	33168322	2021
11	IRT1 and ZIP2 were involved in exogenous hydrogen-rich water-reduced cadmium accumulation in Brassica chinensis and Arabidopsis thaliana. ⁶¹	Wu X...Cui J	33360184	2021
12	Insights into microbial community variability and functional genes of various Candidatus Scalindua-based anammox processes treating nitrogen-rich saline wastewater. ⁶¹	Ma H...Qiang Z	33109367	2021
13	Efficient mineralization of sulfanilamide over oxygen vacancy-rich NiFe-LDH nanosheets array during electro-fenton process. ⁶¹	Younis MA...Hou Y	33352511	2021
14	Efficacy of stem cell-conditioned medium vs. platelet-rich plasma as an adjuvant to ablative fractional CO2 laser resurfacing for atrophic post-acne scars: a split-face clinical trial. ⁶¹	Abdel-Maguid EM...Mekkawy MM	31180258	2021
15	Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials. ⁶¹	Gazendam A...Bhandari M	32829298	2021
16	18F-FDG PET/CT in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: Typical Pattern and Follow-up. ⁶¹	Caquot PA...Morland D	33323741	2021
17	Polysaccaride-rich extract of Caesalpina ferrea stem barks attenuates mice acute inflammation induced by zymosan: Oxidative stress modulation. ⁶¹	Holanda BF...Assreuy AM	33122121	2021
18	Experimental pretreatment with YES-10®, a plant extract rich in scutellarin and chlorogenic acid, protects hippocampal neurons from ischemia/reperfusion injury via antioxidant role. ⁶¹	Park YE...Won MH	33488792	2021
19	Effect of platelet-rich fibrin on the control of alveolar osteitis, pain, trismus, soft tissue healing, and swelling following mandibular third molar surgery: an updated systematic review and meta-analysis. ⁶¹	Zhu J...Xu B	32950350	2021
20	Trace element fixation in sediments rich in organic matter from a saline lake in tropical latitude with hydrothermal inputs (Sochagota Lake, Colombia): The role of bacterial communities. ⁶¹	Cifuentes GR...Jimenez-Espinosa R	33131835	2021
21	Efficient persulfate non-radical activation of electron-rich copper active sites induced by oxygen on graphitic carbon nitride. ⁶¹	Song H...Li D	33162135	2021
22	Physicochemical characteristics and antiproliferative and antioxidant activities of Moroccan Zantaz honey rich in methyl syringate. ⁶¹	Elamine Y...Vioque J	33152883	2021
23	Beware of effects on isotopes of dissolved oxygen during storage of natural iron-rich water samples: A technical note. ⁶¹	Kohler I...Martinez RE	33305417	2021
24	Effects of combination TGF-B1 transfection and platelet rich plasma (PRP) on three-dimension chondrogenic differentiation of rabbit dental pulp-derived mesenchymal stem cells. ⁶¹	Salkin H...Alkan A	31581853	2021
25	Cytosine-Co assemblies derived CoNx rich Co-NCNT as efficient tri-functional electrocatalyst. ⁶¹	Wang Y...Qiu S	33290888	2021
26	Carbon cloth facilitates semi-continuous anaerobic digestion of organic wastewater rich in volatile fatty acids from dark fermentation. ⁶¹	Feng D...Zhu X	33257151	2021
27	Antidiabetic effect of a flavonoid-rich extract from Sophora alopecuroides L. in HFD- and STZ- induced diabetic mice through PKC/GLUT4 pathway and regulating PPARα and PPARγ expression. ⁶¹	Lv Y...Yang X	33271248	2021
28	Microwave-assisted extraction of arabinan-rich pectic polysaccharides from melon peels: Optimization, purification, bioactivity, and techno-functionality. ⁶¹	Golbargi F...Hashemifesharaki R	33483043	2021
29	Reversion-inducing cysteine-rich protein with Kazal motifs and MT1-MMP promote the formation of robust fibrillin fibers. ⁶¹	Matsuzaki T...Noda M	32730638	2021
30	Direct binding of ESCRT protein Chm7 to phosphatidic acid-rich membranes at nuclear envelope herniations. ⁶¹	Thaller DJ...Lusk CP	33464310	2021
31	Machine learning prediction of cellulose-rich materials from biomass pretreatment with ionic liquid solvents. ⁶¹	Phromphithak S...Tippayawong N	33418349	2021
32	Microbial fuel cell improves restoration of Hydrilla verticillata in an algae-rich sediment microcosm system. ⁶¹	Xu P...Wu Z	33248728	2021
33	Raman spectroscopy and high pressure study of synthetic Ga,Ge-rich tourmaline. ⁶¹	Spivak AV...Setkova TV	33277211	2021
34	Letter Regarding: The Effects of Platelet-Rich Plasma to Decrease the Risk of Seroma Formation after Mastectomy and Axillary Dissection. ⁶¹	Spartalis E...Troupis T	33168232	2021
35	Properties and kinetics of the in vitro release of anthocyanin-rich microcapsules produced through spray and freeze-drying complex coacervated double emulsions. ⁶¹	Kanha N...Laokuldilok T	32896780	2021
36	A Simple and Practical Guide for Triaging Lymphocyte-rich Effusions for Ancillary Studies. ⁶¹	Liu CY...Chuang SS	33229932	2021
37	Cocoa-rich chocolate and body composition in postmenopausal women: a randomised clinical trial. ⁶¹	Garcia-Yu IA...Recio-Rodriguez JI	32746952	2021
38	Properties of immobilized MAS1-H108A lipase and its application in the efficient synthesis of n-3 PUFA-rich triacylglycerols. ⁶¹	Wang X...Wang Y	33216225	2021
39	Gene expression of type II collagen is regulated by direct interaction with Kruppel-like factor 4 and AT-rich interactive domain 5B. ⁶¹	Zhang X...Shinomura T	33383116	2021
40	Microplastic degradation by hydroxy-rich bismuth oxychloride. ⁶¹	Jiang R...Wang Y	33087290	2021
41	SEWA DB: A Rich Database for Audio-Visual Emotion and Sentiment Research in the Wild. ⁶¹	Kossaifi J...Pantic M	31581074	2021
42	Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: A simultaneous split-face comparative study. ⁶¹	Pawar M...Singh M	32540414	2021
43	Remediation of artificially contaminated soil and groundwater with copper using hydroxyapatite/calcium silicate hydrate recovered from phosphorus-rich wastewater. ⁶¹	Liu Y...Wang X	33160739	2021
44	Stabilization of acid-rich bio-oil by catalytic mild hydrotreating. ⁶¹	Choi W...Ha JM	33445152	2021
45	Pain after mandibular ramus block harvesting and lateral ridge augmentation with and without involvement of platelet-rich fibrin: a randomized controlled trial. ⁶¹	Hartlev J...Isidor F	32798161	2021
46	Giant cell-rich extrapleural solitary fibrous tumor: Cytological findings and differential diagnosis of a rare neoplasm. ⁶¹	Ronchi A...Palombini L	32940964	2021
47	Ultrafiltration isolation, structures and anti-tumor potentials of two arabinose- and galactose-rich pectins from leaves of Aralia elata. ⁶¹	Shen Y...Xia YG	33436169	2021
48	Green synthesis of boron and nitrogen co-doped TiO2 with rich B-N motifs as Lewis acid-base couples for the effective artificial CO2 photoreduction under simulated sunlight. ⁶¹	Wu D...Jiang K	33279709	2021
49	Composition, antioxidant activity, and neuroprotective effects of anthocyanin-rich extract from purple highland barley bran and its promotion on autophagy. ⁶¹	Zhang Y...Dong M	32858383	2021
50	Density functional theory study on a nitrogen-rich carbon nitride material C3N5 as photocatalyst for CO2 reduction to C1 and C2 products. ⁶¹	Wang Y...Yan L	33183759	2021

Sources

Genes for Rapidly Involuting Congenital Hemangioma

Sources

Variations for Rapidly Involuting Congenital Hemangioma

Cosmic variations for Rapidly Involuting Congenital Hemangioma:

⁹ (show top 50) (show all 1353)

#	Cosmic Mut ID	Gene Symbol	COSMIC Disease Classification (Primary site, Site subtype, Primary histology, Histology subtype)	Mutation CDS	Mutation AA	GRCh38 Location	Conf
1	COSM94290791	XIAP	soft tissue,blood vessel,angiosarcoma,NS	c.73G>C	p.E25Q	23:123885735-123885735	3
2	COSM92181036	XIAP	soft tissue,blood vessel,angiosarcoma,NS	c.73G>C	p.E25Q	23:123885735-123885735	3
3	COSM108084128	XIAP	soft tissue,blood vessel,angiosarcoma,NS	c.73G>C	p.E25Q	23:123885735-123885735	3
4	COSM91383022	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.983G>A	p.W328*	11:32416508-32416508	3
5	COSM148593299	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.983G>A	p.W328*	11:32416508-32416508	3
6	COSM100781781	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.347G>A	p.W116*	11:32416508-32416508	3
7	COSM149739973	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.983G>A	p.W328*	11:32416508-32416508	3
8	COSM130518667	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.314+1069G>A	p.?	11:32416508-32416508	3
9	COSM113485009	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.983G>A	p.W328*	11:32416508-32416508	3
10	COSM111539054	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.950+1069G>A	p.?	11:32416508-32416508	3
11	COSM147426307	WT1	soft tissue,blood vessel,angiosarcoma,NS	c.950+1069G>A	p.?	11:32416508-32416508	3
12	COSM149814991	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
13	COSM151514404	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4510C>T	p.R1504W	16:2085245-2085245	3
14	COSM150365953	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
15	COSM151378978	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
16	COSM151755621	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
17	COSM150324884	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
18	COSM150315618	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4384C>T	p.R1462W	16:2085245-2085245	3
19	COSM102634843	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
20	COSM148983289	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4387C>T	p.R1463W	16:2085245-2085245	3
21	COSM101196039	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2347C>G	p.H783D	16:2074338-2074338	3
22	COSM136629025	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1106G>A	p.W369*	16:2060767-2060767	3
23	COSM87041278	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
24	COSM148996186	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
25	COSM150586941	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
26	COSM147712334	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
27	COSM110114858	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.962G>A	p.W321*	16:2060767-2060767	3
28	COSM136619132	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4417C>T	p.R1473W	16:2085245-2085245	3
29	COSM90415849	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
30	COSM151518304	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
31	COSM110120269	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2383C>G	p.H795D	16:2074338-2074338	3
32	COSM149803740	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4453C>T	p.R1485W	16:2085245-2085245	3
33	COSM150369517	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
34	COSM150584116	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
35	COSM110105462	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4276C>T	p.R1426W	16:2085245-2085245	3
36	COSM90421077	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
37	COSM151371641	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4579C>T	p.R1527W	16:2085245-2085245	3
38	COSM151519993	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
39	COSM149820498	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
40	COSM87029815	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4585C>T	p.R1529W	16:2085245-2085245	3
41	COSM151748696	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4456C>T	p.R1486W	16:2085245-2085245	3
42	COSM101192082	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.926G>A	p.W309*	16:2060767-2060767	3
43	COSM102630453	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
44	COSM148992188	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
45	COSM147707387	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
46	COSM151376817	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
47	COSM87046601	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.2494C>G	p.H832D	16:2074338-2074338	3
48	COSM147694585	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4456C>T	p.R1486W	16:2085245-2085245	3
49	COSM151753419	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.1073G>A	p.W358*	16:2060767-2060767	3
50	COSM101182298	TSC2	soft tissue,blood vessel,angiosarcoma,NS	c.4240C>T	p.R1414W	16:2085245-2085245	3

Sources

Expression for Rapidly Involuting Congenital Hemangioma

Search GEO for disease gene expression data for Rapidly Involuting Congenital Hemangioma.

Sources

Pathways for Rapidly Involuting Congenital Hemangioma

Sources

GO Terms for Rapidly Involuting Congenital Hemangioma

Sources

Sources for Rapidly Involuting Congenital Hemangioma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Mar-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Rapidly Involuting Congenital Hemangioma (RICH)

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Characteristics:

Orphanet epidemiological data:

Classifications:

External Ids:

Summaries for Rapidly Involuting Congenital Hemangioma

Related Diseases for Rapidly Involuting Congenital Hemangioma

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Genetic Tests for Rapidly Involuting Congenital Hemangioma

Anatomical Context for Rapidly Involuting Congenital Hemangioma

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

Publications for Rapidly Involuting Congenital Hemangioma

Articles related to Rapidly Involuting Congenital Hemangioma:

Genes for Rapidly Involuting Congenital Hemangioma

Variations for Rapidly Involuting Congenital Hemangioma

Cosmic variations for Rapidly Involuting Congenital Hemangioma:

Expression for Rapidly Involuting Congenital Hemangioma

Pathways for Rapidly Involuting Congenital Hemangioma

GO Terms for Rapidly Involuting Congenital Hemangioma

Sources for Rapidly Involuting Congenital Hemangioma